Neurodevelopmental Disorders
183
61
73
69
Key Insights
Highlights
Success Rate
99% trial completion (above average)
Research Maturity
69 completed trials (38% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.5%
1 terminated out of 183 trials
98.6%
+12.0% vs benchmark
2%
3 trials in Phase 3/4
10%
7 of 69 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 69 completed trials
Clinical Trials (183)
Genetic Inclusion by Virtual Evaluation
Evaluation of the Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)
Safety and Efficacy of tPBM for Epileptiform Activity in Autism
The Effects of the Melillo Method® on Biopsychosocial Outcomes in School-Age Children
Human Genes and Microbiota in Early Life
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT
Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT (Full Scale RCT)
Prevention of Developmental Delay and Xylitol (PDDaX) Study
Weighted Blankets for Sleep Disturbance Among Children With ADHD
Effect of Probiotics on the Intestinal Microbiota of Pediatric Patients
FAB Programme for Parents of Children With NDD
PACT Programme for Parents of Children With SHCN
Guangzhou Preterm and Term Birth Cohort Study
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game
Air Pollution and Development in the Boricua Youth Study
tES Modalities for the Treatment of ADHD
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
VIPPSTAR-G1 Digital Early Intervention for Visual Impairment